To elucidate the mechanism for hyperlipidemia in the hepatoma-bearing state, changes in some parameters related to the lipid metabolism and serum tumor necrosis factor-(TNF-) level were examined in Donryu rats that had been subcutaneously implanted with an ascites hepatoma cell line of AH109A. These parameters were also examined in rats that had been given a single injection of lipopolysaccharide (LPS), a model for acute infection with TNF-secretion into the blood circulation. The serum triglyceride and total cholesterol (Ch) levels were significantly higher in both the hepatoma-implanted and LPS-injected rats than in normal rats. The level of adipose tissue lipoprotein lipase was decreased by hepatoma implantation and LPS injection, while the hormone-sensitive lipase activity was increased by the same treatments. Fatty acid (FA) oxidation and Ch synthesis were also stimulated by both treatments. The serum TNF-level was noticably elevated by hepatoma implantation and greatly by the LPS injection. This LPS injection increased hepatic FA synthesis. The serum high-density lipoprotein Ch level and hepatic Ch 7-hydroxylase activity were not changed by the LPS injection. Hepatoma implantation led to hyperlipidemia and elevated the serum TNFlevel, as did the LPS injection.
To elucidate the mechanism for hyperlipidemia in the hepatoma-bearing state, changes in some parameters related to the lipid metabolism and serum tumor necrosis factor-(TNF-) level were examined in Donryu rats that had been subcutaneously implanted with an ascites hepatoma cell line of AH109A. These parameters were also examined in rats that had been given a single injection of lipopolysaccharide (LPS), a model for acute infection with TNF-secretion into the blood circulation. The serum triglyceride and total cholesterol (Ch) levels were significantly higher in both the hepatoma-implanted and LPS-injected rats than in normal rats. The level of adipose tissue lipoprotein lipase was decreased by hepatoma implantation and LPS injection, while the hormone-sensitive lipase activity was increased by the same treatments. Fatty acid (FA) oxidation and Ch synthesis were also stimulated by both treatments. The serum TNF-level was noticably elevated by hepatoma implantation and greatly by the LPS injection. This LPS injection increased hepatic FA synthesis. The serum high-density lipoprotein Ch level and hepatic Ch 7-hydroxylase activity were not changed by the LPS injection. Hepatoma implantation led to hyperlipidemia and elevated the serum TNFlevel, as did the LPS injection.
Key words: hepatoma; hypercholesterolemia; hypertriglyceridemia; lipopolysaccharide; tumor necrosis factorVarious types of cancer affect the serum lipoprotein profile in humans. 1, 2) Hepatoma also induces abnormal serum lipid metabolism in humans 3, 4) and animals. 5, 6) Rats subcutaneously implanted with an ascites hepatoma cell line of AH109A showed hyperlipidemia [7] [8] [9] as well as a notable decrease in the high-density lipoprotein (HDL) fraction and an enormous increase in the verylow-density lipoprotein plus low-density lipoprotein (VLDL+LDL) fraction 5, [7] [8] [9] during growth of the hepatoma. AH109A-bearing rats thus provide us with an endogenously hyperlipidemic animal model that is quite distinct from cholesterol (Ch)-loaded animals that have been widely used as an exogenously hypercholesterolemic model. Tumor necrosis factor-(TNF-), one of the cytokines, has been documented to affect the lipid metabolism. For example, TNF-enhances the serum triglyceride (TG) and Ch levels 10, 11) and stimulates hepatic Ch and fatty acid (FA) syntheses. 11) Other reports demonstrate that TNF-suppressed the lipoprotein lipase (LPL) activity 12, 13) and its mRNA levels, 13) and enhanced the lipolysis 12, 14) in cultured fat cells. Lipopolysaccharide (LPS) administration in vivo stimulates TNFsecretion into the blood stream. The results of our previous study have suggested the presence of some common factor(s) involved in the incidence of abnormal lipid metabolism in rats injected with LPS or implanted with hepatoma cells. 8) In the present study, we attempted to elucidate the mechanism for AH109A-induced hyperlipidemia by measuring some parameters related to lipid metabolism and to the serum TNF-level in rats that had been implanted with hepatoma cells as well as in those injected with LPS. 14 C] acetic acid (sodium salt, original specific radioactivity = 2.04 GBq/mmol) was purchased from Amersham International (Buckinghamshire, UK), N-tris (hydroxymethyl) methyl-2-aminoethanesulfonic acid (TES) was obtained from Dojindo (Kumamoto, Japan), and a protein assay kit was from Bio-Rad Laboratories (Richmond, CA, USA).
Materials and Methods

Materials
Animals and diets. Animal experiments were conducted in accordance with criteria established by the Animal Care and Use Committee at Tokyo Noko University. Male Donryu rats (four weeks of age, NRC Haruna, Gunma, Japan) were individually housed in stainless steel cages with wire bottoms in an airconditioned room with a temperature of 22 AE 2 C, a relative humidity of 60 AE 5%, and an 8:00 a.m. to 8:00 p.m. light cycle, and kept on a stock pellet diet (CE-2; CLEA Japan, Tokyo, Japan), and then on a 20% casein (20C) diet.
8) The composition of the 20C diet was as follows: 20% casein, 5% corn oil, 51.3% -cornstarch, 17% sucrose, 3.5% mineral mixture (AIN 76 composition), 15) 1% vitamin mixture (AIN 76 composition), 15) 0.2% choline bitartrate and 2% cellulose powder. After the preliminary feeding, the rats were divided into two groups with similar body weights; one group (n = 6) received a subcutaneous implantation of 5 Â 10
5
AH109A cells (provided by SRL, Tokyo, Japan) suspended in phosphate-buffered saline (PBS(À); 0.5 ml/rat) in the back to produce a solid hepatoma (hepatoma-bearing group), 5) while the other group (n = 12) received a sham injection of PBS(À) alone (0.5 ml/ rat) (normal group). The rats of each group were kept for a further 14 days on the 20C diet, water and the diet being available at all times. On the 14th day after the AH109A implantation, the normal rats were again divided into two groups with similar body weights. Half the rats of the group (n = 6) received an intraperitoneal injection of 2.5 g of LPS diluted in PBS(À) (LPS-injected group) and the other half (n = 6) (normal group) and the hepatoma-bearing group received only an injection of PBS(À) (0.5 ml/rat). These injections were conducted 2 h before killing. This dose of LPS is the minimum level to affect the serum lipid levels and lipid metabolism.
8) The animals were deprived of their diet at 9:00 a.m. on the 14th day, but allowed free access to water until killing which was performed 4 h later by decapitation. Blood was collected and left to clot at room temperature to obtain serum. The liver, epididymal adipose tissue and solid hepatoma were quickly removed, washed with cold 0.9% NaCl, blotted on filter paper, and weighed. Aliquots of the liver and epididymal adipose tissue were frozen in liquid nitrogen and stored at À70 C until needed for analysis.
Lipid analyses. Total lipids were extracted from the liver and solid hepatoma according to the procedure of Folch et al. 16) After portions of the chloroform phase had been dried under nitrogen, Ch, 17) TG 18) and phospholipid (PL) 19) were determined as previously described.
7) The serum TG and PL levels were also determined as described. The serum nonesterified fatty acid (NEFA) level was measured by the method of Kushiro et al. 20) The serum lipoproteins were separated into their HDL and VLDL+LDL fractions by precipitation.
5) The total Ch contents of the unfractionated serum (T-Ch) and HDL (HDL-Ch) were determined by an enzymatic method with a Cholesterol C-test Wako kit, the difference between T-Ch and HDL-Ch being regarded as (VLDL+LDL)-Ch. The ratio of (VLDL+ LDL)-Ch to HDL-Ch is designated as the atherogenic index. The free cholesterol (F-Ch) was measured with a Free Cholesterol C-test Wako kit, the difference between T-Ch and F-Ch being regarded as esterified cholesterol (E-Ch). The ratio of E-Ch to T-Ch is designated as the Ch ratio.
Measurement of the tissue lipolytic activities. LPL was extracted from the epididymal adipose tissue by the method of Noguchi et al.; 21) tissue weighing 300 mg was homogenized in a 0.2 M Tris-HCl buffer (pH = 8.5) containing 10 U/ml of sodium heparin. Hepatic TG lipase (HTGL) was also extracted from the liver in the same way. The lipase (LPL and HTGL) activities were then estimated as described previously. 7, 9, 22, 23) The hormone-sensitive lipase (HSL) activity in the adipose tissue was also determined, HSL being extracted from epididymal adipose tissue with 1 ml of a 25 mM TES buffer (pH = 7.0) by homogenization. 24) After centrifuging the homogenate, the supernatant was applied to a heparin-sepharose column to remove LPL. 25) The unabsorbed fraction was used as the HSL solution. The enzyme solution (0.1 ml) was mixed with 0.1 ml of a substrate solution (an arabic gum-emulsified 0.2 M phosphate buffer at pH = 7.0) containing 925 Bq/mol/ assay of [carboxyl-
14 C] triolein, and the mixture was incubated at 30 C for 1 h. At the end of the incubation period, hydrolyzed [
14 C] oleic acid was extracted, and the radioactivity was counted after adding Insta-Gel. One unit of each lipase activity is defined as 1 mol of FA released per hour.
Hepatic fatty acid oxidation. FA oxidation was estimated by using liver slices. 26) Liver slices weighing 200 mg were placed in 2 ml of a Krebs-Ringer phosphate buffer (pH = 7.4) containing 37 kBq/mol/assay of [1- 14 C] palmitic acid and incubated at 37 C for 2 h. After this period, the oxidation products of FA (CO 2 and ketone bodies) were measured as previously described.
7)
Hepatic lipid syntheses. Total FA and Ch syntheses were measured by using liver slices. 26, 27) Liver slices weighing 100-120 mg were placed in 1 ml of a Krebs-Ringer phosphate buffer (pH = 7.4) containing 37 kBq/ mol/assay of [1-
14 C] acetic acid as the sodium salt, and incubated at 37 C for 2 h. At the end of the incubation period, nonsaponifiable lipids and total FA were extracted and purified. The radioactivity of digitonin-precipitable sterols (Ch) and total FA was counted as described previously.
Cholesterol 7-hydroxylase activity. The cholesterol 7-hydroxylase activity was measured by the method of Van Cantfolt et al. 28) Liver microsomes were prepared by ultracentrifugation, 150 l (about 60 mg of liver) of microsomes being mixed with 500 l of a substrate solution (0.1 M potassium phosphate buffer at pH = 7.4 containing 111 kBq/0.2 mol/assay of [7- 3 H(N)] cholesterol and 250 l of an 8 mM NADPH solution). The mixture was incubated at 37 C for 40 min, before being extracted and tritium water counted. Microsomal protein was measured by the Bradford method 29) with a Bio-Rad Protein Assay kit.
Assay of the serum TNF-level. The serum TNFlevel was measured by a cytotoxic assay using L929 mouse fibroblast cells. 30, 31) L929 cells were seeded at 1:5 Â 10 4 cells per well into a 96-well plate (Nunc, Roskilde, Denmark) in 50 l of an RPMI1640 medium containing 10% fetal calf serum. The plate was incubated for 20 h at 37 C in a 5% CO 2 atmosphere. Twenty-five microliters of serially diluted rat serum or recombinant murine TNF-(Gibco BRL, Gaithersburg, MD, USA) as an internal standard, and 25 l of 4 g/ml of actinomycin D (final concentration = 1 g/ml) were added to each well. The plate was incubated for a further 20 h, before the culture supernatant was removed. The viable cells were stained with crystal violet, washed, and dried. The stained cells in each well were solubilized, and the absorbance at 595 nm was measured with a microplate reader (Bio-Rad Laboratories) as described previously. 32) Statistical analysis. Each result is expressed as the mean AE standard error. The statistical analysis was carried out by Student's t-test between the normal and hepatoma-bearing groups, and between the normal and LPS-injected groups. Table 1 shows the food intake, body weight gain, liver and solid hepatoma weights, and lipid contents in the liver and solid hepatoma 14 days after the AH109A implantation. The food intake, body weight gain, and liver weight were reduced by bearing the hepatoma. The liver TG, PL, and Ch contents were not affected by bearing the hepatoma or LPS injection.
Results
Changes in the serum lipid levels are shown in Table 2 . The serum TG, PL, NEFA, and T-Ch levels were significantly increased by both the hepatoma implantation and LPS injection. The serum F-Ch and E-Ch levels were also increased by the hepatoma implantation and LPS injection, while the Ch ratio (ECh/T-Ch) was significantly decreased by both treatments. The serum HDL-Ch level was significantly reduced by the hepatoma implantation but was unaffected by the LPS injection. The serum (VLDL+LDL)-Ch level was significantly elevated by both treatments. Thus, the atherogenic index ((VLDL+LDL)-Ch/HDLCh) was significantly higher in the hepatoma-bearing and LPS-injected rats than in the normal rats. Table 3 shows the activities of LPL and HSL in the epididymal adipose tissue and of HTGL in the liver. The LPL and HTGL activities were significantly lowered by hepatoma bearing and LPS injection. In contrast to the LPL and HTGL activities, the HSL activity was significantly enhanced by the hepatoma implantation and LPS injection.
FA oxidation, lipid (FA and Ch) syntheses and microsomal Ch 7-hydroxylase activity in the liver are also shown in Table 3 . The production of CO 2 and ketone bodies, and hence total FA oxidation, was higher in both the hepatoma-bearing and LPS-injected rats than in the normal rats. Hepatic FA synthesis was unaffected by bearing the hepatoma, while it was significantly enhanced by LPS the injection. Hepatic Ch synthesis was significantly enhanced by both treatments. The microsomal Ch 7-hydroxylase activity was lower in the hepatoma-bearing rats than in the normal rats; however, the LPS injection exerted no influence on the enzyme activity. Figure 1 illustrates the serum TNF-level which was noticably elevated by the hepatoma implantation and greatly by the LPS injection.
Discussion
The results of the present study show that the serum TG, PL, NEFA, T-Ch, and (VLDL+LDL)-Ch levels were increased in both the hepatoma-bearing and LPStreated rats. The serum TNF-level in the rats was noticably increased by the hepatoma implantation and strikingly so by the LPS injection. Under these circumstances, most of the parameters related to lipid metabolism were changed by the implantation and injection.
A reduction of the LPL activity in the epididymal adipose tissue was seen in the hepatoma-bearing rats. This reduction in LPL activity is one of possible causes of the hypertriglyceridemia that was evident in the AH109A-bearing rats. In our previous studies, an elevated serum TG level and reduced LPL activity in the adipose tissue, cardiac muscle and gastrocnemius were found the day following the implantation of AH109A cells. 9) Likewise, the TNF-produced by the resident peritoneal macrophages primarily cultured from the rats also started to increase the day after the AH109A implantation. 32) These findings on TNF- Analyses of LPL, HTGL, HSL, and Ch 7-hydroxylase activities, hepatic FA oxidation, and hepatic lipid syntheses were carried out as described in the Materials and Methods section. Each value represents the mean AE standard error for six rats. * Significantly different from the normal group at p < 0:05 by Student's t-test. N (À), normal group; H (À), hepatoma-implanted group; N (þ), LPS-injected group.
indicate that the hosts rapidly responded to the hepatoma inoculation.
Another possibility for the cause of the AH109A-induced hypertriglyceridemia is the enhanced FA mobilization from the adipose tissue. The hepatic FA synthesis per unit weight did not differ in the hepatomabearing rats as compared with normal rats. Liver weight in hepatoma-bearing rats was less than that in normal rats, so the total FA synthesis in the liver might have been lower in the hepatoma-bearing rats. FA mobilization from adipose tissue was enhanced in the hepatomabearing rats. Elevated serum NEFA would provide a source of FA for the increase in hepatic TG production and hence TG secretion. This increase in the serum NEFA level is considered to have been due to the elevation in HSL activity of the adipose tissue. Hepatic FA oxidation was enhanced in the hepatoma-bearing rats. Some FA might have been more preferably oxidized than esterified to TG from the results of the present study.
Hepatic Ch synthesis was stimulated and microsomal Ch 7-hydroxylase activity was reduced in the hepatoma-bearing rats. Ch 7-hydroxylase is the rate-limiting enzyme for Ch catabolism and bile acid synthesis. The results of our previous study showed that the neutral sterol and bile acid excretion into the feces was decreased by AH109A implantation. 7, 9) It is likely that increased cholesterogenesis in the liver, decreased Ch 7-hydroxylase activity, and decreased steroid excretion into the feces may have been the causes for the hypercholesterolemia induced in those rats implanted with AH109A.
An elevation in the serum TG and T-Ch levels was seen in the rats injected with LPS, like the effect in the rats implanted with the hepatoma, although some of the parameters related to lipid metabolism responded differently to AH109A implantation and LPS injection. LPS injection increased the hepatic FA synthesis which is thought to have been one of the causes for LPS-injected hypertriglyceridemia. In the present study, increased FA synthesis and decreased LPL activity was simultaneously apparent in the LPS-injected rats. However, the severity of the hypertriglyceridemia induced by LPS injection was weaker than that induced by AH109A implantation under the experimental conditions used here. This may have been due to the slightly lower levels of LPL and HTGL in the LPS-injected rats than in the AH109A-implanted animals. The serum HDL-Ch level and hepatic Ch 7-hydroxylase activity were not affected by the LPS injection. The quantity and quality of HDL are known to be modified by LPL. 33) As already mentioned, the LPL activity in adipose and muscular tissues was found to be lower the day following the implantation of AH109A cells. 9) Nevertheless, the HDL-Ch level of the AH109A-bearing rats remained unchanged for the first week and thereafter declined approximately linearly with the growth of the hepatoma. 5) These findings indicate a lag period before the modification of LPL to HDL which may have been responsible for the unchanged level of HDL-Ch in the LPS-injected rats with acutely reduced LPL activity. The hepatic Ch 7-hydroxylase activity is known to be affected by feeding.
34) The food consumption by the hepatoma-bearing rats was lower than that by the normal rats, while it remained unchanged in the LPS-administered rats. This may be one reason for different responses of Ch 7-hydroxylase activity to the hepatoma implantation (decreased activity) and LPS injection (unchanged activity).
The serum TNF-level in the LPS-injected rats was higher than that in the hepatoma-bearing rats, whereas the serum TG and T-Ch levels in the LPS-injected rats were lower than the levels in the hepatoma-bearing rats. In the LPS-treated animals, the serum TG and T-Ch levels 16 h and 24 h after LPS implantation were higher than those at 4 h and 8 h after. 35) In the present study, blood was collected 2 h after the LPS injection, so a small increase in the serum lipid levels might have been seen in the LPS-treated rats when compared with the hepatoma-bearing rats.
In conclusion, AH109A implantation led to hyperlipidemia and elevated the serum TNF-level, as did LPS injection. TNF-is known to affect lipid metabolism, and has been demonstrated to suppress the LPL activity and enhance the lipolysis in cultured adipocytes, 12) or to stimulate hepatic Ch synthesis. 11) TNFmay be, at least in part, involved in the induction of hyperlipidemia in hepatoma-bearing rats through these actions of cytokine on the lipid metabolism. Lipid metabolism is regulated by various factors, including cytokines and hormones. For example, interleukin-1 increased the serum TG level, 36) and insulin enhanced the LPL activity and its mRNA level. 37) If AH109A-bearing rats show increased interleukin-1 production or decreased insulin secretion, these changes may play a hypotriglyceridemic role in the AH109A-bearing rats. Further studies are needed to clarify this aspect.
